AG
CLVS
Artal Group’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Hold |
0
| – | – | – | 150 |
|
|
2020
Q2 | – | Sell |
-1,000,000
| Closed | -$6.36M | – | 132 |
|
|
2020
Q1 | $6.36M | Hold |
1,000,000
| – | – | 0.27% | 53 |
|
|
2019
Q4 | $10.4M | Buy |
1,000,000
+500,000
| +100% | +$5.21M | 0.4% | 41 |
|
|
2019
Q3 | $1.97M | Buy |
+500,000
| New | +$1.97M | 0.08% | 84 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 110 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 105 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 108 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 108 |
|
|
2018
Q1 | – | Sell |
-100,000
| Closed | -$6.8M | – | 125 |
|
|
2017
Q4 | $6.8M | Sell |
100,000
-15,000
| -13% | -$1.02M | 0.1% | 30 |
|
|
2017
Q3 | $9.48M | Buy |
115,000
+90,000
| +360% | +$7.42M | 0.16% | 23 |
|
|
2017
Q2 | $2.34M | Buy |
+25,000
| New | +$2.34M | 0.04% | 65 |
|
|
2017
Q1 | – | Sell |
-50,000
| Closed | -$2.22M | – | 95 |
|
|
2016
Q4 | $2.22M | Buy |
+50,000
| New | +$2.22M | 0.05% | 48 |
|